This technology describes compositions and methods for controllable local delivery of therapeutic agents to promote bone formation. This technology can be used to develop treatments for clinical indications such as osteoporosis, bone cancer and fractures.
This technology can be honed so that the therapeutic agents are specifically targeted to a site in need of bone formation.